CTOs on the Move

GN Resound

www.gnresound.com

 
GN ReSound is the undisputed technology leader in the global hearing instrument market and is one of several divisions of GN Great Nordic. To learn more about our parent company, Great Nordic, please click on the link below.
  • Number of Employees: 250-1000
  • Annual Revenue: $50-100 Million
  • www.gnresound.com
  • 8001 E Bloomington Fwy
    Minneapolis, MN USA 55420
  • Phone: 952.769.8000

Executives

Name Title Contact Details

Similar Companies

Region Ten Community Services Board

Region Ten Community Services Board is a Charlottesville, VA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Binson's Home Health Care Centers

Binson's Home Health Care Centers is a Center Line, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Tethys Bioscience

Tethys Bioscience is a personalized predictive medicine company developing novel tests which address the growing global healthcare challenge of chronic diseases such as diabetes.

Duos

DUOS is reimagining freedom at any age. As a technology-enabled service provider, DUOS connects people to the essential resources required to attain the highest level of health. Our advanced technology allows us to aggregate historically siloed data and resources from across the ecosystem, breaking down barriers to health literacy and access to care and enabling seamless and timely connections with complete visibility and feedback throughout the process.

CancerLinQ

CancerLinQ, a subsidiary of ASCO, is a mission-driven, non-profit health technology company focused on improving quality of care, advancing biomedical research, and improving health outcomes for all patients with cancer. Backed by ASCO, CancerLinQ`s products and services reflect a deep understanding of the needs of oncologists, cancer centers, and researchers. We are bilingual by design: fluent in both the language of oncology and technology. As a trusted partner to over 100 cancer centers and community oncology practices, CancerLinQ is uniquely positioned to advance cancer care and research.